REVICKI DA, OSOBA D, FAIRCLOUGH D, BAROFSKY I, BERZON R, LEIDY NK,R...
2.
Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK,
Rothman M: Recommendations on health-related quality of
however be useful for the detection of non-compliantlife research to support labeling and promotional claims in
patients. A regular intake of the prescribed immunosup-the United States. Qual Life Res 2000, 9:887-900.
pressive drugs is key to prevent graft rejection in these sub-